Kelun Biotech publishes sac TMT breast cancer study in Annals of Oncology
Sichuan Kelun Biotech Biopharmaceutical published overall survival analysis from its Phase III OptiTROP Breast01 study in Annals of Oncology during the ESMO Congress in Madrid
We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.